| scholarly article | Q13442814 |
| P50 | author | Fereshteh Karimzadeh | Q81232782 |
| P2093 | author name string | Nathalie Lamarche-Vane | |
| Christine Caron | |||
| Patrick Fournier | |||
| Vilayphone Luangrath | |||
| Isabelle Royal | |||
| Jonathan DeGeer | |||
| Philippe M Duquette | |||
| Hidetaka Ishii | |||
| P2860 | cites work | Gain-of-function mutations of ARHGAP31, a Cdc42/Rac1 GTPase regulator, cause syndromic cutis aplasia and limb anomalies | Q24626495 |
| Regulation of Small GTPases by GEFs, GAPs, and GDIs | Q26825750 | ||
| Rho GAPs and GEFs: controling switches in endothelial cell adhesion | Q26992281 | ||
| Molecular control of endothelial cell behaviour during blood vessel morphogenesis | Q27007664 | ||
| The focal adhesion-localized CdGAP regulates matrix rigidity sensing and durotaxis | Q27315836 | ||
| Recessive mutations in DOCK6, encoding the guanidine nucleotide exchange factor DOCK6, lead to abnormal actin cytoskeleton organization and Adams-Oliver syndrome | Q28244970 | ||
| The spectra of clinical phenotypes in aplasia cutis congenita and terminal transverse limb defects | Q28252346 | ||
| Haploinsufficiency of the NOTCH1 Receptor as a Cause of Adams-Oliver Syndrome With Variable Cardiac Anomalies | Q28261852 | ||
| Heterozygous Loss-of-Function Mutations in DLL4 Cause Adams-Oliver Syndrome | Q28266515 | ||
| RBPJ mutations identified in two families affected by Adams-Oliver syndrome | Q28272822 | ||
| Mutations in EOGT confirm the genetic heterogeneity of autosomal-recessive Adams-Oliver syndrome | Q28287700 | ||
| Essential role of endothelial Notch1 in angiogenesis | Q28509482 | ||
| Role of Gab1 in heart, placenta, and skin development and growth factor- and cytokine-induced extracellular signal-regulated kinase mitogen-activated protein kinase activation | Q28589835 | ||
| Molecular mechanisms and clinical applications of angiogenesis | Q29547314 | ||
| Mechanisms of angiogenesis | Q29547485 | ||
| Angiogenesis in health and disease | Q29614541 | ||
| Basic and Therapeutic Aspects of Angiogenesis | Q29615219 | ||
| CdGAP, a novel proline-rich GTPase-activating protein for Cdc42 and Rac. | Q30176009 | ||
| Therapeutic angiogenesis for critical limb ischaemia | Q30456666 | ||
| CdGAP regulates cell migration and adhesion dynamics in two‐and three‐dimensional matrix environments | Q30654973 | ||
| A Snail1/Notch1 signalling axis controls embryonic vascular development. | Q33736954 | ||
| Rac regulates endothelial morphogenesis and capillary assembly | Q33893806 | ||
| Initiation of hematopoiesis and vasculogenesis in murine yolk sac explants | Q52207278 | ||
| DOCK6 mutations are responsible for a distinct autosomal-recessive variant of Adams-Oliver syndrome associated with brain and eye anomalies | Q52868262 | ||
| Tyrosine phosphorylation of DEP-1/CD148 as a mechanism controlling Src kinase activation, endothelial cell permeability, invasion, and capillary formation. | Q54490381 | ||
| Docking protein Gab1 is an essential component of postnatal angiogenesis after ischemia via HGF/c-met signaling. | Q54615405 | ||
| CdGAP is required for transforming growth factor β- and Neu/ErbB-2-induced breast cancer cell motility and invasion. | Q54636285 | ||
| Diffuse angiopathy in Adams-Oliver syndrome associated with truncating DOCK6 mutations. | Q55656450 | ||
| Cardiovascular malformations in Adams-Oliver syndrome | Q58193220 | ||
| Use of the mouse aortic ring assay to study angiogenesis | Q58313759 | ||
| Isolated terminal limb reduction defects: Extending the clinical spectrum of Adams-Oliver syndrome andARHGAP31mutations | Q62937117 | ||
| The adaptor protein Gab1 couples the stimulation of vascular endothelial growth factor receptor-2 to the activation of phosphoinositide 3-kinase | Q64377712 | ||
| Signal transduction by vascular endothelial growth factor receptors | Q84520249 | ||
| Endothelial Akt1 mediates angiogenesis by phosphorylating multiple angiogenic substrates | Q34144300 | ||
| Identification of vascular and hematopoietic genes downstream of etsrp by deep sequencing in zebrafish | Q34206023 | ||
| Generation of a conditional null allele of NADPH oxidase activator 1 (NOXA1) | Q34436701 | ||
| The human orthologue of CdGAP is a phosphoprotein and a GTPase-activating protein for Cdc42 and Rac1 but not RhoA. | Q34499924 | ||
| Grb-2-associated binder 1 (Gab1) regulates postnatal ischemic and VEGF-induced angiogenesis through the protein kinase A-endothelial NOS pathway | Q34582584 | ||
| Glycogen synthase kinase-3 phosphorylates CdGAP at a consensus ERK 1 regulatory site | Q34589399 | ||
| Notch signaling in vascular development and physiology | Q34646081 | ||
| Activation of cdc42, rac, PAK, and rho-kinase in response to hepatocyte growth factor differentially regulates epithelial cell colony spreading and dissociation | Q34712138 | ||
| Endothelial Grb2-associated binder 1 is crucial for postnatal angiogenesis | Q34980011 | ||
| Peakwide mapping on chromosome 3q13 identifies the kalirin gene as a novel candidate gene for coronary artery disease | Q35752509 | ||
| VEGF-induced Rac1 activation in endothelial cells is regulated by the guanine nucleotide exchange factor Vav2 | Q36082465 | ||
| Current knowledge of the large RhoGAP family of proteins | Q36707513 | ||
| Regulation of endothelial nitric oxide synthase and postnatal angiogenesis by Rac1. | Q37041713 | ||
| Angiogenesis: a team effort coordinated by notch. | Q37393190 | ||
| Regulation of angiogenesis by ETS transcription factors | Q37631641 | ||
| Angiogenesis and vasculogenesis in rheumatoid arthritis. | Q37715688 | ||
| Developmental and pathological angiogenesis | Q37901035 | ||
| Regulation of Endothelial Cell Differentiation and Specification | Q38101895 | ||
| Genetics of aplasia cutis reveal novel regulators of skin morphogenesis. | Q38263745 | ||
| Non-redundant roles of the Gab1 and Gab2 scaffolding adapters in VEGF-mediated signalling, migration, and survival of endothelial cells | Q39881261 | ||
| The scaffolding adapter Gab1 mediates vascular endothelial growth factor signaling and is required for endothelial cell migration and capillary formation. | Q40193180 | ||
| CdGAP associates with actopaxin to regulate integrin-dependent changes in cell morphology and motility | Q40252534 | ||
| Rac Regulates Vascular Endothelial Growth Factor Stimulated Motility | Q40759315 | ||
| Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis | Q42482049 | ||
| An essential role for Rac1 in endothelial cell function and vascular development. | Q46775495 | ||
| Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo. | Q46930160 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 27485 | |
| P577 | publication date | 2016-06-07 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | CdGAP/ARHGAP31, a Cdc42/Rac1 GTPase regulator, is critical for vascular development and VEGF-mediated angiogenesis | |
| P478 | volume | 6 |
| Q89910312 | CD226 deletion improves post-infarction healing via modulating macrophage polarization in mice |
| Q52653012 | CdGAP/ARHGAP31 is regulated by RSK phosphorylation and binding to 14-3-3β adaptor protein. |
| Q88513806 | Cytosine methylation predicts renal function decline in American Indians |
| Q41592601 | Development and Characterization of VEGF165-Chitosan Nanoparticles for the Treatment of Radiation-Induced Skin Injury in Rats |
| Q38991996 | The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer |
| Q41503844 | The scaffold protein Ajuba suppresses CdGAP activity in epithelia to maintain stable cell-cell contacts |
| Q89697179 | Weighted Single-Step Genome-Wide Association Study for Growth Traits in Chinese Simmental Beef Cattle |
Search more.